drugset / Trial / NCT07720271

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

NCT07720271 ↗

Phase 3 Recruiting 950 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as oral tablets once a day. Participants will either get zenagamtide (the treatment being tested) or Placebo (treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Timeline

Start
2026-08-31
Primary completion
2028-06-27
Completion
2028-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Zenagamtide Unknown — Oral

Indications